Visium Asset Management’s Elevance Health ELV Stock Holding History

Visium Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-150,000	Closed	-$20.8M	–	391
2016 Q1	$20.8M	Sell	150,000 -161,300	-52%	-$21.6M	0.35%	65
2015 Q4	$43.4M	Buy	+311,300	New	+$42.9M	0.65%	27
2015 Q3	–	Sell	-1,442	Closed	-$237K	–	977
2015 Q2	$237K	Sell	1,442 -758,785	-100%	-$121M	﹤0.01%	915
2015 Q1	$117M	Buy	760,227 +120,395	+19%	+$17.1M	1.73%	8
2014 Q4	$80.4M	Sell	639,832 -449,236	-41%	-$55.5M	1.14%	11
2014 Q3	$130M	Buy	1,089,068 +977,029	+872%	+$112M	1.92%	6
2014 Q2	$12.1M	Buy	112,039 +27,593	+33%	+$2.84M	0.19%	105
2014 Q1	$8.41M	Sell	84,446 -90,574	-52%	-$8.19M	0.14%	144
2013 Q4	$16.2M	Sell	175,020 -91,130	-34%	-$8.1M	0.32%	64
2013 Q3	$22.3M	Buy	266,150 +40,533	+18%	+$3.47M	0.5%	45
2013 Q2	$18.5M	Buy	+225,617	New	+$16.9M	0.43%	50

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Visium Asset Management's ELV Position: Q2 2016 in Review

Visium Asset Management sold out of Elevance Health (ELV) in Q2 2016, closing a stake of 150,000 shares — an estimated $20.8M sold.

Visium Asset Management first reported a position in ELV in Q2 2013 and held it in 11 quarters. The position peaked at $130M in Q3 2014. 759 funds tracked by Wall St. Rank hold ELV as of Q2 2016.

Visium Asset Management reported no remaining Elevance Health position as of Q2 2016 after selling out during the quarter.
Visium Asset Management sold 150,000 Elevance Health shares in Q2 2016, an estimated $20.8M.
Visium Asset Management first reported a position in Elevance Health in Q2 2013 and held it in 11 quarters.
Visium Asset Management's Elevance Health position peaked at $130M in Q3 2014.
759 funds tracked by Wall St. Rank held Elevance Health as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.